The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures.
暂无分享,去创建一个
A. Hofman | A. Uitterlinden | F. Rivadeneira | N. van der Velde | L. Stolk | S. Heil | J. Meurs | R. de Jonge | M. Zillikens | A. Enneman | J. V. van Meurs | A. Uitterlinden | A. Hofman | R. D. Jonge | N. V. D. Velde | Sandra G. Heil
[1] A. Uitterlinden,et al. Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence , 2011, BMC geriatrics.
[2] T. Siebel,et al. High bone concentrations of homocysteine are associated with altered bone morphology in humans. , 2011, The British journal of nutrition.
[3] R. Jonge,et al. Pneumocystis pneumonia and measurement of S-adenosylmethionine plasma levels , 2011 .
[4] M. Blauth,et al. Outcome in geriatric fracture patients and how it can be improved , 2010, Osteoporosis International.
[5] U. Ozekıcı,et al. Erratum to: Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women , 2010, Archives of Gynecology and Obstetrics.
[6] H. Blom,et al. Inhibition of methylation decreases osteoblast differentiation via a non-DNA-dependent methylation mechanism. , 2010, Bone.
[7] J. V. van Meurs,et al. Body mass index is an important determinant of methylation biomarkers in women of reproductive ages. , 2009, The Journal of nutrition.
[8] A. LaCroix,et al. Homocysteine levels and risk of hip fracture in postmenopausal women. , 2009, The Journal of clinical endocrinology and metabolism.
[9] Britt Wildemann,et al. Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. , 2009, Bone.
[10] J. Eisman,et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. , 2009, JAMA.
[11] Monique M. B. Breteler,et al. The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.
[12] J. Beilby,et al. The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women , 2009, Osteoporosis International.
[13] Satoshi Inoue,et al. The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures , 2008, Journal of Bone and Mineral Metabolism.
[14] L. Bouter,et al. Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study. , 2008, Clinical science.
[15] B. Bagni,et al. Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. , 2008, Bone.
[16] J. Riancho,et al. MTHFR C677T Polymorphism and Osteoporotic Fractures , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[17] S. Vollset,et al. Plasma Homocysteine, Folate, and Vitamin B12 and the Risk of Hip Fracture: The Hordaland Homocysteine Study , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] W. Herrmann,et al. The role of hyperhomocysteinemia as well as folate, vitamin B6 and B12 deficiencies in osteoporosis – a systematic review , 2007, Clinical chemistry and laboratory medicine.
[19] J. Riancho,et al. MTHFR Polymorphism and Bone Mineral Density: Meta-Analysis of Published Studies , 2006, Calcified Tissue International.
[20] S. Vollset,et al. Plasma total homocysteine level and bone mineral density: the Hordaland Homocysteine Study. , 2006, Archives of internal medicine.
[21] A. Favier,et al. A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice , 2006, Clinical chemistry and laboratory medicine.
[22] H. Blom,et al. Stable-isotope dilution liquid chromatography-electrospray injection tandem mass spectrometry method for fast, selective measurement of S-adenosylmethionine and S-adenosylhomocysteine in plasma. , 2005, Clinical chemistry.
[23] B. Langdahl,et al. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD , 2005, Osteoporosis International.
[24] O. Johnell,et al. Requirements for DXA for the management of osteoporosis in Europe , 2005, Osteoporosis International.
[25] A. Hofman,et al. Homocysteine levels and the risk of osteoporotic fracture. , 2004, The New England journal of medicine.
[26] D. Kiel,et al. Homocysteine as a predictive factor for hip fracture in older persons. , 2004, The New England journal of medicine.
[27] B. Abrahamsen,et al. Association of a Common Allelic Polymorphism (C677T) in the Methylene Tetrahydrofolate Reductase Gene with a Reduced Risk of Osteoporotic Fractures. A Case Control Study in Danish Postmenopausal Women , 2002, Calcified Tissue International.
[28] I. Pogribny,et al. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. , 2001, The Journal of nutrition.
[29] W. Haefeli,et al. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease. , 2001, Atherosclerosis.
[30] I. Pogribny,et al. Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation* , 2000, The Journal of Biological Chemistry.
[31] H. Blom,et al. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. , 1996, Biochimica et biophysica acta.
[32] Harry K. Genant,et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. , 1993, The American journal of medicine.
[33] G. Cantoni,et al. The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine. , 1959, The Journal of biological chemistry.